Case study
W1.2 Vaccine Manufacturing at Lab Scale: A paradigm shift to more affordable vaccines
A novel way of manufacturing: case study low-cost inactivated polio vaccine
Authors
Languages
- English
Publication year
2021
Type
Case study
Categories
- Global initiatives
Diseases
- Polio
Topic references
GVIRF-2021
